ProfileGDS4718 / 207484_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 67% 71% 67% 73% 72% 66% 69% 67% 71% 68% 64% 70% 71% 69% 64% 65% 67% 70% 67% 76% 63% 65% 67% 68% 68% 67% 69% 67% 66% 67% 71% 66% 71% 66% 68% 68% 67% 70% 70% 64% 70% 71% 64% 67% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.6181767
GSM549102patient 115, normal, homogenized [OPG study]6.9012971
GSM549104patient 119, normal, homogenized [OPG study]6.6819567
GSM549108patient 138, normal, homogenized [OPG study]7.1095873
GSM549119patient 077, normal, homogenized [OPG study]7.0347372
GSM549133patient 032, cancer, homogenized [OPG study]6.5320466
GSM549139patient 042, cancer, homogenized [OPG study]6.8026869
GSM549099patient 107, normal, homogenized [OPG study]6.6113667
GSM549109patient 139, normal, homogenized [OPG study]6.8942171
GSM549110patient 046, normal, homogenized [OPG study]6.6809768
GSM549114patient 063, normal, homogenized [OPG study]6.3573464
GSM549122patient 082, normal, homogenized [OPG study]6.8553670
GSM549134patient 033, cancer, homogenized [OPG study]6.9995771
GSM549136patient 036, cancer, homogenized [OPG study]6.8180769
GSM549140patient 044, cancer, homogenized [OPG study]6.4407564
GSM549111patient 047, normal, homogenized [OPG study]6.4863565
GSM549113patient 057, normal, homogenized [OPG study]6.6086767
GSM549132patient 031, cancer, homogenized [OPG study]6.8731170
GSM549137patient 038, cancer, homogenized [OPG study]6.6386867
GSM549142patient 047, cancer, homogenized [OPG study]7.2767176
GSM549100patient 110, normal, homogenized [OPG study]6.2869263
GSM549107patient 135, normal, homogenized [OPG study]6.4515465
GSM549115patient 068, normal, homogenized [OPG study]6.6708367
GSM549116patient 072, normal, homogenized [OPG study]6.6871668
GSM549120patient 078, normal, homogenized [OPG study]6.6722568
GSM549131patient 030, cancer, homogenized [OPG study]6.6599867
GSM549118patient 074, normal, homogenized [OPG study]6.7867669
GSM549129patient 027, cancer, homogenized [OPG study]6.7256967
GSM549123patient 088, normal, homogenized [OPG study]6.5635666
GSM549124patient 006, cancer, homogenized [OPG study]6.6262267
GSM549126patient 015, cancer, homogenized [OPG study]6.9177671
GSM549128patient 025, cancer, homogenized [OPG study]6.6316166
GSM549103patient 117, normal, homogenized [OPG study]6.8811471
GSM549117patient 073, normal, homogenized [OPG study]6.5225966
GSM549138patient 041, cancer, homogenized [OPG study]6.7459168
GSM549141patient 045, cancer, homogenized [OPG study]6.7569568
GSM549130patient 028, cancer, homogenized [OPG study]6.6498967
GSM549101patient 111, normal, homogenized [OPG study]6.8445470
GSM549105patient 128, normal, homogenized [OPG study]6.8788870
GSM549106patient 134, normal, homogenized [OPG study]6.4598564
GSM549112patient 048, normal, homogenized [OPG study]6.8414370
GSM549125patient 011, cancer, homogenized [OPG study]6.9224971
GSM549127patient 024, cancer, homogenized [OPG study]6.4822164
GSM549135patient 035, cancer, homogenized [OPG study]6.6315767